Alhamad, T <br/><br/>
Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Apr 2016 
 - 1332-3 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1600-6143 
<br/><br/><label>Standard No.: </label>10.1111/ajt.13711  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Graft Rejection--etiology<br/>Graft Survival<br/>Humans<br/>Kidney Failure, Chronic--complications<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Melanoma--drug therapy<br/>Postoperative Complications<br/>Prognosis<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Risk Factors<br/>Skin Neoplasms--drug therapy<br/>Transplant Recipients